ProQuest Investments

The record

Every round we can evidence, newest first39 appearances

1. 2014

   2 rounds

2. Nov
   SomaLogicVenture · US$17MSole investor
3. Aug
   Mevion Medical SystemsGrowth · US$200MWith 5 others
4. 2013

   5 rounds

5. Dec
   TelormedixSeries B · CH · unquote.com$7.9MWith 1 other
6. Oct
   Immune DesignSeries C · US · finsmes.com$49MWith 6 others
7. Jul
   ReVision OpticsSeries E · US · finsmes.com$55MWith 5 others
8. Jun
   Mevion Medical SystemsGrowth · US · finsmes.com$55MWith 3 others
9. Apr
   ReVision OpticsSeries E · US · sec.gov$15MWith 4 others
10. 2012

    4 rounds

11. Jul
    Mersana TherapeuticsSeries A · US · finsmes.com$27MWith 4 others
12. Jul
    Agile TherapeuticsSeries C · US · finsmes.com$40MWith 5 others
13. Feb
    TelormedixSeries B · CH · onbiovc.com$8.3MWith 1 other
14. Jan
    Mevion Medical SystemsVenture · US · mevion.com$45MWith 2 others
15. 2011

    1 round

16. Sept
    MethylGeneVenture · CA · sec.gov$35MWith 2 others
17. 2010

    4 rounds

18. Jul
    Immune DesignSeries B · US · xconomy.com$32MWith 4 others
19. Jul
    ReVision OpticsSeries D · US · onbiovc.com$35MWith 3 others
20. Jun
    Predictive BiosciencesSeries C · US · onbiovc.com$25MWith 4 others
21. Apr
    TragaraSeries B · US · onbiovc.com$5.0MWith 4 others
22. 2009

    7 rounds

23. Aug
    Gloucester PharmaceuticalsSeries D · US · gloucesterpharma.com$29MWith 4 others
24. Aug
    BiosyntechVenture · CA · biosyntech.com$1.4MWith 3 others
25. Aug
    Zosano PharmaSeries B · US · onbiovc.com$30MWith 3 others
26. May
    Clovis OncologyGrowth · US$145MWith 6 others
27. May
    Clovis OncologySeries A · US · onbiovc.com$145MWith 6 others
28. Apr
    OrthoconSeries B · US · pehub.com$25MWith 2 others
29. Apr
    AerovanceVenture · US · venturebeat.com$38MWith 7 others
30. 2008

    1 round

31. Jul
    Gemin X PharmaceuticalsSeries C · CA · siliconindia.com$38MWith 12 others
32. 2007

    4 rounds

33. Nov
    Excaliard PharmaceuticalsSeries A · US · excaliard.com$16MWith 2 others
34. Nov
    Zosano PharmaSeries A · US · zosanopharma.com$90MWith 3 others
35. Nov
    LEAD TherapeuticsSeries A · US · leadtherapeutics.com$17MWith 2 others
36. Mar
    TragaraSeries A · US$40MWith 4 others
37. 2005

    3 rounds

38. Dec
    Optimer PharmaceuticalsSeries D · US$22MWith 7 others
39. Nov
    Mersana TherapeuticsVenture · US · mersana.com$21MWith 7 others
40. Jul
    EUSA PharmaVenture · GB$14MWith 1 other
41. 2004

    4 rounds

42. Sept
    Sopherion TherapeuticsSeries B · US$47MWith 7 others
43. Mar
    BioRexisSeries B$30MWith 6 others
44. Jan
    Threshold PharmaceuticalsSeries B · US$41MWith 6 others
45. Jan
    NovaceaSeries C · US$35MWith 5 others
46. 2003

    1 round

47. Mar
    Sopherion TherapeuticsSeries A · US$26MWith 7 others
48. 2002

    2 rounds

49. Dec
    BioRexisSeries A$8.0MWith 2 others
50. Oct
    PharmionVenture · US$40MWith 5 others
51. 2001

    1 round

52. Jun
    Guava TechnologiesSeries B · US$18MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed12 in all

An exit counts when it came after the firm's first round in the company. From historical deal records.